We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Vor Biopharma Inc | NASDAQ:VOR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.005 | -0.29% | 1.71 | 1.70 | 1.72 | 1.73 | 1.68 | 1.72 | 81,754 | 17:01:28 |
23rd Annual Needham Virtual Healthcare ConferenceFireside Chat: Tuesday, April 9, 2024 at 3:45 pm ET Location: Virtual
Chardan's 8th Annual Genetic Medicines + Cell Therapy Manufacturing SummitFireside Chat: Monday, April 29, 2024 at 9:30 am ET Location: Virtual
About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com
1 Year Vor Biopharma Chart |
1 Month Vor Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions